Alberto Borghetti

Focal status epilepticus as unique clinical feature of COVID-19: A case report

Catello Vollono, Eleonora Rollo, Marina Romozzi et al. · Seizure · 2020 · 203 citations · Full text

Long Covid, Unique Clinical Feature, Covid-19 Pandemic +3

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

Mattia Prosperi, Massimiliano Fabbiani, Iuri Fanti et al. · BMC Infectious Diseases · 2012 · 90 citations · Full text

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quirós-Roldán et al. · Journal of Antimicrobial Chemotherapy · 2016 · 75 citations · Full text

Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study

Roberta Gagliardini, Arturo Ciccullo, Alberto Borghetti et al. · Open Forum Infectious Diseases · 2018 · 63 citations · Full text

Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients

Gianmaria Baldin, Arturo Ciccullo, Stefano Rusconi et al. · International Journal of Antimicrobial Agents · 2019 · 54 citations · Full text

Treatment And Prevention, Antiviral Drug Development, Antiviral Therapy +7